Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 Global Alzheimer’s Disease Trials: 10 Factors to Consider By Sebastian Turek November 29, 2017 Clinical ResearchPhase 1 - Phase 4 Where Do We Start?: A Look at Dosing in Phase 1 Trials By Abie Ekangaki November 29, 2017 Consulting The Placebo Problem, Part 13: The Pediatric Placebo Response By Scott Millard November 21, 2017 Patient and Stakeholder Engagement 7 Ways to Engage Military Vets in PTSD Clinical Trials By Denise Bedoya November 10, 2017 Clinical ResearchPhase 1 - Phase 4 The Placebo Problem, Part 12: The Nocebo Response By Scott Millard November 8, 2017 Clinical ResearchPhase 1 - Phase 4 Against the Odds: Achieving Fast Startup in a Sickle Cell Drug Trial By Premier Research November 1, 2017 Previous 1 …36 37 38 39 40 … 56 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today